In the past 12‑18 months the Veterinary Arthroscopy Device market has accelerated through strategic collaborations, tech roll‑outs, and regulatory refinements. In March 2023, ArthroVet partnered with MediTech Imaging to integrate AI‑driven joint‑space visualization into its handheld scopes, promising faster diagnosis for equine and companion‑animal practices. July 2023 saw the acquisition of SurgiScope Ltd. by Global MedDevices, expanding the latter’s portfolio with miniaturized 2.7 mm arthroscopes tailored for small‑animal orthopedics. Early 2024 introduced the first hybrid fiber‑laser arthroscope from ClearView Instruments, which combines high‑definition optics with on‑board tissue‑ablation, a technology now cleared by the EU’s MDR for veterinary use. The U.S. FDA’s updated “Veterinary Device Classification” guidance, released in February 2024, streamlines 510(k) pathways for arthroscopic tools, encouraging faster market entry. Meanwhile, a $45 million Series B round led by HealthVentures enabled VetScope Innovations to scale production in Brazil, positioning the company to meet rising demand from emerging markets. Collectively, these moves signal a shift toward AI‑enhanced, minimally invasive solutions and underscore the momentum behind Veterinary Arthroscopy Device industry trends.